Marusyk Andriy, Polyak Kornelia
Department of Medical Oncology, Dana-Farber Cancer Institute, Department of Medicine, Brigham and Women's Hospital, Department of Medicine, Harvard Medical School, 44 Binney Street, Boston, MA 02115, USA.
Biochim Biophys Acta. 2010 Jan;1805(1):105-17. doi: 10.1016/j.bbcan.2009.11.002. Epub 2009 Nov 18.
With rare exceptions, spontaneous tumors originate from a single cell. Yet, at the time of clinical diagnosis, the majority of human tumors display startling heterogeneity in many morphological and physiological features, such as expression of cell surface receptors, proliferative and angiogenic potential. To a substantial extent, this heterogeneity might be attributed to morphological and epigenetic plasticity, but there is also strong evidence for the co-existence of genetically divergent tumor cell clones within tumors. In this perspective, we summarize the sources of intra-tumor phenotypic heterogeneity with emphasis on genetic heterogeneity. We review experimental evidence for the existence of both intra-tumor clonal heterogeneity as well as frequent evolutionary divergence between primary tumors and metastatic outgrowths. Furthermore, we discuss potential biological and clinical implications of intra-tumor clonal heterogeneity.
除极少数例外情况外,自发肿瘤起源于单个细胞。然而,在临床诊断时,大多数人类肿瘤在许多形态和生理特征方面表现出惊人的异质性,如细胞表面受体的表达、增殖和血管生成潜力。在很大程度上,这种异质性可能归因于形态和表观遗传可塑性,但也有强有力的证据表明肿瘤内存在基因不同的肿瘤细胞克隆。从这个角度出发,我们总结了肿瘤内表型异质性的来源,重点是基因异质性。我们回顾了肿瘤内克隆异质性以及原发性肿瘤和转移灶之间频繁进化差异存在的实验证据。此外,我们还讨论了肿瘤内克隆异质性的潜在生物学和临床意义。